BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30578840)

  • 1. TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls.
    Hishizawa M; Yamashita H; Akizuki M; Urushitani M; Takahashi R
    Neurochem Int; 2019 Mar; 124():41-45. PubMed ID: 30578840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis.
    Nielsen AK; Folke J; Owczarek S; Svenstrup K; Winge K; Pakkenberg B; Aznar S; Brudek T
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33361387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M
    Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis.
    Williams SM; Khan G; Harris BT; Ravits J; Sierks MR
    BMC Neurosci; 2017 Jan; 18(1):20. PubMed ID: 28122516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis.
    Verstraete E; Kuiperij HB; van Blitterswijk MM; Veldink JH; Schelhaas HJ; van den Berg LH; Verbeek MM
    Amyotroph Lateral Scler; 2012 Sep; 13(5):446-51. PubMed ID: 22873561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
    Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H
    Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
    Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
    Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics.
    Kojima Y; Kasai T; Noto YI; Ohmichi T; Tatebe H; Kitaoji T; Tsuji Y; Kitani-Morii F; Shinomoto M; Allsop D; Teramukai S; Mizuno T; Tokuda T
    PLoS One; 2021; 16(11):e0260323. PubMed ID: 34843548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The implications of TDP-43 mutations in pathogenesis of amyotrophic lateral sclerosis].
    Ishihara T; Yokoseki A; Nishizawa M; Takahashi H; Onodera O
    Brain Nerve; 2009 Nov; 61(11):1301-7. PubMed ID: 19938687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis.
    Sasaki S; Takeda T; Shibata N; Kobayashi M
    Neurosci Lett; 2010 Jul; 478(2):72-6. PubMed ID: 20447446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of RNA metabolism in peripheral WBCs of TDP-43 KI mice identifies novel biomarkers of ALS.
    Hasegawa M; Hara-Miyauchi C; Ohta H; Sakimura K; Okano H; Okano HJ
    Neurosci Res; 2016 May; 106():12-22. PubMed ID: 26672899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
    MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
    Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
    Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
    Braak H; Ludolph A; Thal DR; Del Tredici K
    Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
    Kwak S
    Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.